Ibuprofen and Diphenhydramine Hydrochloride Modified-Release Tablets(Taizhou Overseas Pharma)

复方布洛芬多释片（越洋医药）

Report date: 2025/07/31 17:39:29

Base Information

Drug NameIbuprofen and Diphenhydramine Hydrochloride Modified-Release Tablets(Taizhou Overseas Pharma)
Drug Alias NameDiphenhydramine/Ibuprofen盐酸苯海拉明/布洛芬Diphenhydramine Hydrochloride/Ibuprofen布洛芬/盐酸苯海拉明Diphenhydramine Hydrochloride and Ibuprofen +[6] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHistamine H1 receptor inverse agonistsCyclooxygenases inhibitors
TargetsHistamine H1 receptorCyclooxygenases
Therapy Area/IndicationsPainSleep Initiation and Maintenance Disorders
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsYes
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesTaizhou Overseas Pharmaceuticals Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesTaizhou Overseas Pharmaceuticals Co Ltd
Inactive CompaniesN/A
Active IndicationsPainSleep Initiation and Maintenance Disorders
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A